CAS: 389621-84-5; (4-(Morpholine-4-Carbonyl)Phenyl)Boronic Acid

该化合物是一种碳基替代物的碳酸衍生物,其成分为氨基碳基替代物,使其成为有机合成和制药应用中有价值的中间体;溴酸混合物能够将其用于铃木-米亚乌拉的交叉反应,有助于形成复杂的分子构造中的碳-碳联系;氨基碳基化合物组可增强溶性和再活动性,特别是在药物设计和开发的药用化学中.该化合物在标准处理条件下表现出稳定性,确保合成工作流程的可靠性能.其结构多用途性使其适合于催化剂,离心和生物活性化合物合成的应用.为研究和工业用途保持了高纯度和一贯的质量.

结构式图片

欧盟法规

C&L通报

上下游产品

4-(4-Iodobenzoyl)morpholine N-(4-chlorobenzoyl)morpholine morpholine (4-(chlor°Carbonyl)phenyl)boronic acid N-(3-fluoro-4-(1-(4-methoxybenzyl)-3-(4-(morpholine-4-carbonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide 5-(3-fluoro-4-(1-(4-methoxybenzyl)-3-(4-(morpholine-4-carbonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)phenyl)-3-methyl-2-(phenylamino)pyrimidin-4(3H)-one (4-(4-(4-amino-2-fluorophenoxy)-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)(morpholino)methanone 2-(cyclohexylmethyl)-5-(3-fluoro-4-(1-(4-methoxybenzyl)-3-(4-(morpholine-4-carbonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)phenyl)-3-methylpyrimidin-4(3H)-one

合成工艺路线路线简述

    📜4-(4-碘苯甲酰基)吗啉置于双二甲胺基乙基醚,异丙基氯化镁,硼酸三甲酯,盐酸,水体系中,用 四氢呋喃 作为反应溶剂,化学反应 2.67H,反应生成 4-(吗啉-4-羰基)苯基硼酸
    参考文献: Carbazole And Carboline Kinase Inhibitors[fr] Carbazole Et Inhibiteurs De La Carboline Kinase
    标题: Carbazole And Carboline Kinase Inhibitors[fr] Carbazole Et Inhibiteurs De La Carboline Kinase
    摘要:本发明提供了式(i)的化合物及其药用可接受的盐.式(i)的化合物抑制jak2的酪氨酸激酶活性,因此使它们在作为抗增殖剂治疗癌症和其他疾病方面有用.

    海关参考信息

    专利信息


    专利号:US-9938258-B2
    优先权日:2012-11-29
    标 题:Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
    发明人:BALOGLU ERKAN; SHECHTER SHARON; SHACHAM SHARON; MCCAULEY DILARA; SENAPEDIS WILLIAM; GOLAN GALI; KALID ORI
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula I: n nor a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

    专利号:US-9856241-B2
    优先权日:2013-07-03
    标 题:Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (A), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知